Abstract
Biotechnology Law ReportVol. 39, No. 5 As presented by Chris HolmanIdorsia Pharmaceuticals, Ltd. v. Iancu United States Court of Appeals of the Federal Circuit, 2020 811 Fed. Appx. 650 (nonprecedential)Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN*Published Online:7 Oct 2020https://doi.org/10.1089/blr.2020.29198.cmhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 39Issue 5Oct 2020 InformationCopyright 2020, Mary Ann Liebert, Inc., publishersTo cite this article:Idorsia Pharmaceuticals, Ltd. v. Iancu United States Court of Appeals of the Federal Circuit, 2020 811 Fed. Appx. 650 (nonprecedential).Biotechnology Law Report.Oct 2020.406-408.http://doi.org/10.1089/blr.2020.29198.cmhPublished in Volume: 39 Issue 5: October 7, 2020PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
